Dr. Melvin M. Seek, MD

Dr. Seek practices at Palatka Dialysis in Ocala, Florida.

Dr. Seek's NPI, 1043218043, was assigned on July 13, 2005. Dr. Seek graduated from UMKC School of Medicine in 1979. Dr. Seek holds Florida license ME48556.

Dr. Seek's primary practice is Palatka Dialysis, at 3291 Sw 17th Ave, Ocala, FL 34471 in Marion County. The practice phone is (386) 329-9458.

Dr. Seek's primary practice is Palatka Dialysis in Ocala, Florida. Dr. Seek is also affiliated with HCA Florida Ocala Hospital. The medical group on file is Ocala Kidney Group. Dmand AI also links Dr. Seek to 4 more hospitals, 5 dialysis centers, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seek practices, 13 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Seek's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Seek is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Seek's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Seek treats.

CMS data shows 2,209 Medicare services from Dr. Seek across 14 procedure codes in 2024, for 452 Medicare patients. Medicare paid $284,145 for them.

CMS counts 452 Medicare patients who saw Dr. Seek in 2024. The largest group is 75 to 84, with 188 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 3.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seek's median patient age at 72, with 41% women.

In 2024, Dr. Seek wrote 1,059 Medicare Part D claims for 153 patients. 90% of them were for generic drugs. CMS names the drug for 763 of them, across 38 drugs with 11 or more claims each, at $91,750 in total drug cost. In 2023, CMS named 626 claims across 30 drugs.

Dr. Seek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Seek, published from 2017 to 2021. Dr. Seek's most frequent co-authors are Brendan T. Bowman, MD, Hassan Amin, MD and John Robert Brandt, MD.

Dmand AI links Dr. Seek to 1 clinical trial. Conditions studied include Renal Insufficiency, Chronic and Renal Insufficiency.

CMS Open Payments shows 90 general payments to Dr. Seek from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abiomed paid the most, $1,560. It also lists 12 research payments totaling $75,703 from 2022 to 2024.

Dmand AI lists 1 award for Dr. Seek, most recently CMS Stage 1 EHR in 2013.

Dr. Seek graduated from UMKC School of Medicine in 1979.

Dr. Seek is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.